Filter by:
Revita
ADA, June 2018
Duodenal Mucosal Resurfacing Elicits Improvement in Glycemic and Hepatic Parameters in Type 2 Diabetes: 1 Year Multicenter Study Results
van Baar, et al. presented poster at 78th American Diabetes Association Scientific Sessions (ADA). Orlando, Florida, USA, June 2018.
RejuvaRevita
AHA, November 2017
The Economic Burden of Insulin Resistance, Obesity, and Cardiovascular Disease in Medicare Beneficiaries 65 Years of Age and Older
Sacks, et al. presented poster at American Heart Association Meeting (AHA). Anaheim, Calif., USA, November 2017.
Revita
AASLD, October 2017
Improvement in Hepatic Transaminases Over 12 Months After Single Procedure Duodenal Mucosal Resurfacing in Type 2 Diabetes Patients
van Baar, et al. presented poster at American Association for the Study of Liver Diseases (AASLD). Washington, DC, USA, October 2017.
Revita
EASD, September 2017
Duodenal Mucosal Resurfacing demonstrates sustained improvement in glycaemic parameters in type 2 diabetes: 12 month data
van Baar, et al. presented poster at 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD). Lisbon, Portugal, September 2017.
Revita
NASH, July 2017
Duodenal Mucosa: A Target for Treating Metabolic Liver Disease in NASH and T2D
Rajagopalan presented at 3rd Paris Nash Meeting. Paris, France, July 2017.
Revita
DDW, May 2017.
Single Catheter for Duodenal Mucosal Resurfacing Demonstrates Similar Safety Profile With Improved Procedure Time When Compared to Original Dual Catheter: Multicenter Study of Subjects With Type 2 Diabetes
van Baar, et al. presented poster at Digestive Disease Week (DDW). Chicago, Illinois, USA, May 2017.
Revita
Gastrointestinal Endoscopy Clinics of North America, 27(2): 299-311, April 2017.
Hydrothermal Duodenal Mucosal Resurfacing Role in the Treatment of Metabolic Disease
Cherrington, et al.
Revita
AASLD, November 2016.
Endoscopic duodenal mucosal resurfacing (DMR) improves insulin sensitivity, hepatic transaminase levels and anti-inflammatory markers in subjects with type 2 diabetes
Rajagopalan, et al. presented poster at American Association for the Study of Liver Diseases (AASLD). Boston, Massachusetts, USA, November 2016.
Revita
AASLD, November 2016
A single endoscopic duodenal mucosal resurfacing procedure exerts a sustained improvement in hepatic transaminase levels in a cohort of type 2 diabetes patients
van Baar, et al. presented poster at American Association for the Study of Liver Diseases (AASLD). Boston, Massachusetts, USA, November 2016.